[1]李守淼,李子禹,季鑫.Siewert Ⅱ型胃食管结合部腺癌淋巴结转移的特点[J].中华肿瘤杂志,2013,35(4):288-291.
LI SM,LI ZY,JI X.Clinical characteristics of lymph node metastasis metastasis in Siewert type Ⅱ adenocarcinoma of the gastroesophageal junction[J].Chinese Journal of Oncology,2013,35(4):288-291.
[2]TAKAYA S,SAITO H,IKEGUCHI M.Upregulation of immune checkpoint molecules,PD-1 and LAG-3,on CD4+and CD8+T cells after gastric cancer surgery[J].Yonago Acta Med,2015,58(1):39-44.
[3]ANANTH AA,TAI LH,LANSDELL C,et al.Surgical stress abrogates pre-existing protective t cell mediated anti-tumor immunity leading to postoperative cancer recurrence[J].PLoS One,2016,11(5):e0155947.
[4]WASIUK P,PUTOWSKI M,GIANNOPOULOS K.PD1/PD1L pathway,HLA-G and T regulatory cells as new markers of immunosuppression in cancers[J].Postepy Hig Med Dosw(Online),2016,70(0):1044-1058.
[5]CHEN L,SUN L,LANG Y,et al.Fast-track surgery improves postoperative clinical recovery and cellular and humoral immunity after esophagectomy for esophageal cancer[J].BMC Cancer,2016(16):449.
[6]李守淼,张志忠,张伟,等.食管胃交界部腺癌术后腹腔热灌注化疗对细胞免疫的影响[J].中华普通外科杂志,2017,32(12):1047-1049.
LI SM,ZHANG ZZ,ZHANG W,et al.Influence of hyperthermic intraperitoneal perfusion chemotherapy on cellular immune function in adenocarcinoma of esophagogastric junction after radical operation[J].Chinese Journal of General Surgery,2017,32(12):1047-1049.
[7]徐志云,刘良,杨立信,等.淋巴结清扫数目对淋巴结转移阴性Siewert Ⅱ型食管胃交界部癌的影响[J].实用医学杂志,2016,32(23):3878-3881.
XU ZY,LIU L,YANG LX,et al.Survival analysis the impact of the number of negative lymph nodes negative lymph node in Siewert Ⅱ adenocarcinoma of the esophagogastrci junction without lymphatic metastasis[J].The Journal of Practical Medicine,2016,32(23):3878-3881.
[8]RICE TW,PATIL DT,BLACKSTONE EH.8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction:Application to clinical practice[J].Ann Cardiothorac Surg,2017,6(2):119-130.
[9]YUAN XL,CHEN L,ZHANG TT,et al.Gastric cancer cells induce human CD4+Foxp3+regulatory T cells through the production of TGF-β1[J].World J Gastroenterol,2011,17(15):2019-2027.
[10]SCHMIDT A,ERIKSSON M,SHANG MM,et al.Comparative analysis of protocols to induce human CD4+Foxp3+regulatory t cells by combinations of IL-2,TGF-beta,retinoic acid,rapamycin and butyrate[J].PLoS One,2016,11(2):e0148474.
[11]DELEEUW RJ,KROEGER DR,KOST SE,et al.CD25 identifies a subset of CD4+FoxP3- TIL that are exhausted yet prognostically favorable in human ovarian cancer[J].Cancer Immunol Res,2015,3(3):245-253.
[12]PAKKALA S,OWONIKOKO TK.Immune checkpoint inhibitors in small cell lung cancer[J].J Thorac Dis,2018,10(Suppl 3):S460-S467.
[13]XU P,ZHANG P,SUN Z,et al.Surgical trauma induces postoperative T-cell dysfunction in lung cancer patients through the programmed death-1 pathway[J].Cancer Immunol Immunother,2015,64(11):1383-1392.
[14]SAITO H,KURODA H,MATSUNAGA T,et al.Increased PD-1 expression on CD4+and CD8+T cells is involved in immune evasion in gastric cancer[J].J Surg Oncol,2013,107(5):517-522.
[15]HASE S,WEINITSCHKE K,FISCHER K,et al.Monitoring peri-operative immune suppression in renal cancer patients[J].Oncol Rep,2011,25(5):1455-1464.
[16]SELLITTO A,GALIZIA G,DE FANIS U,et al.Behavior of circulating CD4+CD25+Foxp3+regulatory T cells in colon cancer patients undergoing surgery[J].J Clin Immunol,2011,31(6):1095-1104.
[17]WU M,CHEN X,LOU J,et al.Changes in regulatory T cells in patients with ovarian cancer undergoing surgery:Preliminary results[J].Int Immunopharmacol,2017,47:244-250.
[18]ZHANG CH,HUANG Y.Effect of peripheral blood CD4+CD25+ regulatory T cell on postoperative immunotherapy for patients with renal carcinoma[J].Asian Pac J Cancer Prev,2016,17(4):2027-2030.
[19]LI Y,ZHOU L,SUN B,et al.Interleukin-2 administration after modified radical mastectomy in breast cancer therapy increases peripheral regulatory T cells[J].Int J Clin Exp Med,2015,8(5):7816-7822.
[20]ZHANG S,PAN SB,LYU QH,et al.Postoperative regulatory T-cells and natural killer cells in stage i nonsmall cell lung cancer underwent video-assisted thoracoscopic lobectomy or thoracotomy[J].Chin Med J(Engl),2015,128(11):1502-1509.